Henry Schein

What Henry Schein does

Henry Schein, Inc. (Nasdaq: HSIC) is a Fortune 500 healthcare distribution and technology company founded in 1932 and headquartered in Melville, New York. The company distributes more than 300,000 branded and corporate-brand products through a centralized network of 55 distribution and manufacturing centers across 34 countries, serving over 1 million office-based dental and medical practitioners, dental laboratories, dental service organizations (DSOs), and government/institutional clinics. Its core go-to-market combines a direct field sales force, inside sales, and the HenrySchein.com ecommerce platform, which now processes over 80% of US dental ecommerce volume. Henry Schein also supplies integrated practice management software (Dentrix, Dentrix Ascend, Dentrix Enterprise), specialty modules (OMSVision, EndoVision, PerioVision), business intelligence (Jarvis Analytics), digital marketing (Henry Schein One), AI workflow tools (Image Verify), financial services, and continuing education through Viva Learning.

The business generates revenue through four principal streams: transactional distribution of dental and medical supplies and equipment (the largest stream), subscription-based practice management software and technology, one-time dental equipment sales bundled with ProRepair service contracts, and professional services including practice financing, patient financing, credit card processing, and consulting. Pricing is quote-based with volume discounts and promotional programs, and the company supplements organic distribution with an aggressive M&A strategy (Shield Healthcare, Biotech Dental, S.I.N. Implant System, TriMed, eAssist, Regional Health Care Group, Condor Dental, and S.I.N. 360) to extend into home care, dental implants, digital dentistry, orthopedic extremities, and international markets.

The company is publicly traded on NASDAQ, employs 25,000+ Team Schein Members globally, and operates with $1.8 billion in total liquidity following a $750 million credit facility. Leadership transitioned in 2026: Frederick M. Lowery became CEO in March 2026 succeeding Stanley M. Bergman after 35 years; William K. "Dan" Daniel was elected Independent Chairman in May 2026. Henry Schein holds 35-40% estimated share in US and other dental distribution markets, has been recognized as one of the World's Most Ethical Companies for 15 consecutive years by Ethisphere, and reports FY2025 sales of $13.2 billion (6.3% YoY growth), with a stated value-creation initiative targeting $125 million of run-rate operating income improvement by year-end 2026.

Name

Henry Schein

Legal name

Henry Schein, Inc.

Website

https://henryschein.com

Company type

Public

Founded year

1932

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Henry Schein (Nasdaq: HSIC) is a Fortune 500 distributor of dental, medical, and animal-health supplies serving over 1 million office-based practitioners across 34 countries, complemented by Dentrix practice management software, AI workflow tools, financial services, and specialty acquisitions in implants and home care.

Ownership category

akta.pro rank

Product category

Healthcare Distribution (Dental and Medical Supplies)

NAICS

Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (42345)

SIC

Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Dental Equipment & Supplies (3843), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Medical, Dental & Lab Supply Marketplaces (CRAFAHAG)

Keywords

• Dental supplies distribution
• Medical supplies distribution
• Practice management software
• Healthcare distribution services
• Dental practice solutions

Headquarters

HQ city

Melville

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Dental and Medical Product Distribution: Core revenue stream from distribution of dental and medical supplies, equipment, and products to office-based practitioners. The company offers over 300,000 branded and corporate brand products through direct sales and ecommerce channels. Revenue is generated through transactional product sales with recurring customer relationships.
2. Practice Management Software and Technology: Software subscriptions and technology solutions including Dentrix, Dentrix Ascend, Dentrix Enterprise, Henry Schein One, and related practice management platforms. Revenue from software licensing, subscriptions, and support services.
3. Dental Equipment Sales and Service: Sales of dental equipment including capital equipment, technology solutions, and in-office service and repair offerings through ProRepair and related service programs.
4. Financial Services: Practice financing, equipment leasing, patient financing, credit card processing, and practice consulting services offered to dental and medical practitioners.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels7 records

Core offering

Henry Schein distributes more than 300,000 branded and corporate-brand healthcare products to office-based dental, medical, and animal-health practitioners through a centralized, automated network of 55 distribution and manufacturing centers in 34 countries, serving over 1 million customers. The company complements product distribution with an integrated portfolio of practice-management software (Dentrix, Dentrix Ascend, Dentrix Enterprise, Henry Schein One), specialty dental laboratory and orthodontic divisions, financial services, and AI-powered clinical workflow tools.

Product overview

Henry Schein is a dental and medical distribution company with a comprehensive portfolio spanning supplies, equipment, and technology solutions. The core offering includes over 300,000 branded products distributed through centralized and automated networks to over 1 million customers globally. The company operates two primary business segments: Dental (supplies, equipment, practice management software) and Medical (supplies, equipment, point-of-care diagnostics). Practice management software is centered on the Dentrix platform family (Dentrix for general practices, Dentrix Ascend cloud-based solution, and Dentrix Enterprise for large DSOs and government clinics), supplemented by specialty modules for oral surgery (OMSVision), endodontics (EndoVision), and periodontics (PerioVision), along with Jarvis Analytics for business intelligence and Henry Schein One for digital marketing. Financial services include revenue cycle management, patient financing, and practice consulting. The technology portfolio includes the CitoCBC point-of-care diagnostic system, AI-powered Image Verify for claims quality assurance, and AI clinical workflow tools. Henry Schein has pursued aggressive acquisition strategy, acquiring Biotech Dental (digital dentistry), S.I.N. Implant System (dental implants), eAssist Dental Solutions (billing outsourcing), Shield Healthcare (home care), Regional Health Care Group (Australia/New Zealand), and TriMed (orthopedics) to expand into specialty segments and geographic markets.

Differentiator

Problem solved

Functional benefit

Products and services

• Dentrix
• Dentrix Ascend
• Dentrix Enterprise
• Henry Schein One
• axiUm
• Henry Schein Financial Services
• Henry Schein ProRepair
• Henry Schein Medical
• Zahn Dental Laboratories
• Henry Schein Orthodontics
• Henry Schein Special Markets
• BioHorizons
• Camlog
• CitoCBC System
• Curodont Repair Fluoride Plus
• VELscope Mantis
• Zirlux Independence ML
• Shield Healthcare
• TriMed
• S.I.N. Implant System
• Biotech Dental
• eAssist Dental Solutions

Quantifiable outcome

• 99% order fulfillment rate historically
• +3 more outcomes

Named customers9 records

Segments6 records

Ideal customer profiles6 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability6 records

Feature4 records

Partnerships

Four partnerships are on record, tiered core.

• Amazon Web Services (AWS)coreTechnology or Integration · 10 March 2026Strategic partnership with AWS for AI integration into Henry Schein's platform. Company presented at Barclays Global Healthcare Conference highlighting digital expansion and AI integration initiatives.
• CytoChip Inc.coreChannel Partner/ Reseller/ Distributor · 15 January 2026Exclusive distribution agreement for the CitoCBC system - the first cartridge-based Complete Blood Count device to receive CLIA waiver from the FDA, delivering full CBC results in approximately eight minutes using fluorescent flow cytometry technology.
• vVARDIScoreChannel Partner/ Reseller/ Distributor · 12 January 2026Expanded partnership making Henry Schein the exclusive US distributor for Curodont Repair Fluoride Plus starting January 1, 2026. vVARDIS founders presented at the 2026 J.P. Morgan Healthcare Conference, highlighting treating over 2 million teeth in the US within 24 months and $85 million funding from OrbiMed.
• Extremity Medical LLCcoreStrategic or Co-development Partner · 20 December 2023Strategic partnership with Extremity Medical LLC to strengthen Henry Schein's position in extremities markets. This partnership supports the company's entry into the orthopedic extremities market segment following the acquisition of TriMed, Inc.

Scale indicators10 records

Recent moves7 records

Expansion highlights7 records

Direct peers

• Patterson Companies: Patterson Companies is one of Henry Schein's two largest direct competitors in North American dental and animal health distribution, with overlapping product portfolios serving dental practices and similar go-to-market via field sales reps and ecommerce. Highly comparable on business model, customer base, and category exposure.
• Benco Dental: Benco Dental is a privately held, full-service dental distributor directly competing with Henry Schein in US dental supply, equipment, and practice solutions. Comparable on customer base (dental practices) and product breadth (300,000+ SKUs), though smaller in scale.
• Darby Dental: Darby Dental (now part of Dental Health Products, Inc. / Spencer) is a major US dental supply distributor that competes directly with Henry Schein and Patterson for office-based dental practitioners. Comparable product portfolio, customer base, and ecommerce-led distribution model.

Broad incumbents

• McKesson Corporation: McKesson is a Fortune 10 healthcare distribution giant with a broad medical supply and pharmaceutical distribution business that overlaps with Henry Schein's medical segment. While not a focused dental distributor, McKesson represents scale competition in medical distribution and has explored the dental vertical.
• Cardinal Health: Cardinal Health is a major US medical product distributor serving physician offices, hospitals, and ambulatory sites with overlapping supply chain capabilities. It competes with Henry Schein's Medical segment as a broad incumbent with deeper hospital channel relationships.
• Owens & Minor: Owens & Minor distributes medical and surgical supplies to hospitals, ambulatory surgery centers, and physician offices, with overlap in Henry Schein's medical distribution business. A broad incumbent with similar supply chain economics but more hospital-channel focused.
• Dentsply Sirona: Dentsply Sirona is a leading global manufacturer of dental equipment, implants, and consumables that Henry Schein both distributes (creating partnership tension) and competes with indirectly. Highly comparable product category, though as a manufacturer it represents an upstream/downstream dynamic to Henry Schein's distributor model.
• Envista Holdings: Envista Holdings (spun off from Danaher, where incoming chairman William Daniel previously oversaw the dental portfolio) is a major dental equipment and consumables manufacturer. Overlaps with Henry Schein's product lines (equipment, implants, orthodontics) and is both a supplier partner and competitive threat.

Emerging players

• Concordance Healthcare Solutions: Concordance Healthcare Solutions is a US medical/surgical distributor formed through roll-ups of smaller regional distributors, competing with Henry Schein's medical segment for physician office and alternate site customers. An emerging player with growing scale and comparable distribution model.
• PaxeraHealth: PaxeraHealth (formerly known for imaging and dental AI solutions) and similar dental technology vendors represent emerging competition in the AI-enabled clinical workflow space where Henry Schein is investing via Image Verify and AWS partnership. Comparable target market (dental practices) with different technology focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/henryschein
• LinkedInlinkedin.com/company/henry-schein
• Xx.com/henryschein

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries14 records

Funding overview

Funding rounds5 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A52 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Henry Schein